EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis

Ling Jiang, Yu Zhao, Fang Liu, Yun Huang, Yujiao Zhang, Baoyi Yuan, Jiaying Cheng, Ping Yan, Jinle Ni, Yongshuai Jiang, Quan Wu, Xuejie Jiang

Cell Communication and Signaling · 07.08.2024 · 22 (1)

DOI: 10.1186/s12964-024-01774-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Communication and Signaling, online erschienen am 07.08.2024. Verfasst von Ling Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Leukemia, Myeloid, Acute, Glycogen Synthase Kinase 3 beta, beta Catenin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

fms-Like Tyrosine Kinase 3Leukemia, Myeloid, AcuteGlycogen Synthase Kinase 3 betabeta CateninPhosphotransferases (Alcohol Group Acceptor)Protein Phosphatase 2HumansAnimalsMiceCell Line, TumorSorafenibApoptosisProtein Kinase InhibitorsSignal TransductionCell ProliferationDrug SynergismXenograft Model Antitumor AssaysDrug Resistance, NeoplasmSphingosine Kinase

Stichwörter der Autor:innen

Acute myeloid leukemiaFLT3SPHK1SphingolipidTyrosine kinase inhibitorΒ-catenin

Substanzen

fms-Like Tyrosine Kinase 3Glycogen Synthase Kinase 3 betabeta CateninPhosphotransferases (Alcohol Group Acceptor)Protein Phosphatase 2SorafenibProtein Kinase InhibitorsSphingosine KinaseFLT3 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • School of Medicine, Zhengzhou University, Zhengzhou, China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. jxj3331233@163.com.

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Jiang, L., Zhao, Y., Liu, F., Huang, Y., Zhang, Y., Yuan, B., Cheng, J., Yan, P., Ni, J., Jiang, Y., Wu, Q., & Jiang, X. (2024). Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis. Cell Communication and Signaling, 22(1). https://doi.org/10.1186/s12964-024-01774-9

Vancouver

Jiang L, Zhao Y, Liu F, Huang Y, Zhang Y, Yuan B, et al. Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis. Cell Communication and Signaling. 2024;22(1). doi:10.1186/s12964-024-01774-9

BibTeX
@article{Jiang2024,
  author = {Jiang, Ling and Zhao, Yu and Liu, Fang and Huang, Yun and Zhang, Yujiao and Yuan, Baoyi and Cheng, Jiaying and Yan, Ping and Ni, Jinle and Jiang, Yongshuai and Wu, Quan and Jiang, Xuejie},
  title = {Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis},
  journal = {Cell Communication and Signaling},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12964-024-01774-9}
}
Kostenlos starten →